Basic Information | Post buying leads | Suppliers |
Name |
Zimeldine hydrochloride |
EINECS | N/A |
CAS No. | 60525-15-7 | Density | 1.286g/cm3 |
PSA | 16.13000 | LogP | 4.63940 |
Solubility | N/A | Melting Point |
N/A |
Formula | C16H17BrN2•2ClH | Boiling Point | 412.8°C at 760 mmHg |
Molecular Weight | 390.15 | Flash Point | 203.4°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. Human systemic effects: ataxia, diarrhea, fasciculations, hypermotility, jaundice. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Br−, NOx, and HCl. See also ZIMELIDINE. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)allylamine dihydrochloride |
EINECS of Zimeldine hydrochloride (CAS NO.60525-15-7): 262-279-7
Empirical Formula: C16H19BrCl2N2
Molecular Weight: 390.1455 g/mol
Flash Point: 203.4 °C
Enthalpy of Vaporization: 66.55 kJ/mol
Boiling Point: 412.8 °C at 760 mmHg
Vapour Pressure: 5.05E-07 mmHg at 25 °C
Structure of Zimeldine hydrochloride (CAS NO.60525-15-7):
IUPAC Name: (Z)-3-(4-Bromophenyl)-N,N-dimethyl-3-pyridin-3-ylprop-2-en-1-aminedihydrochloride
Canonical SMILES: CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2.Cl.Cl
Isomeric SMILES: CN(C)C/C=C(/C1=CC=C(C=C1)Br)\C2=CN=CC=C2.Cl.Cl
InChI: InChI=1S/C16H17BrN2.2ClH/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13;;/h3-10,12H,11H2,1-2H3;2*1H/b16-9-;;
InChIKey: CXGURXWCQYHDIR-ULPVBNQHSA-N
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | oral | 80mg/kg (80mg/kg) | Acta Pharmaceutica Suecica. Vol. 20, Pg. 295, 1983. | |
dog | LD50 | intravenous | 57mg/kg (57mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. | |
dog | LD50 | oral | 271mg/kg (271mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. | |
man | TDLo | oral | 36mg/kg (36mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | British Medical Journal. Vol. 287, Pg. 1672, 1983. |
mouse | LD50 | intraperitoneal | 84400ug/kg (84.4mg/kg) | Acta Pharmaceutica Suecica. Vol. 20, Pg. 295, 1983. | |
mouse | LD50 | intravenous | 27700ug/kg (27.7mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. |
mouse | LD50 | oral | 341mg/kg (341mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. |
mouse | LD50 | subcutaneous | 154mg/kg (154mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. |
rabbit | LD50 | intravenous | 50800ug/kg (50.8mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. |
rabbit | LD50 | oral | 300mg/kg (300mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. |
rat | LD50 | intraperitoneal | 99800ug/kg (99.8mg/kg) | Acta Pharmaceutica Suecica. Vol. 20, Pg. 295, 1983. | |
rat | LD50 | intravenous | 45800ug/kg (45.8mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 1833, 1983. |
rat | LD50 | oral | 844mg/kg (844mg/kg) | Acta Pharmaceutica Suecica. Vol. 20, Pg. 295, 1983. | |
rat | LD50 | subcutaneous | 227mg/kg (227mg/kg) | Acta Pharmaceutica Suecica. Vol. 20, Pg. 295, 1983. | |
women | TDLo | oral | 12mg/kg/6D-I (12mg/kg) | PERIPHERAL NERVE AND SENSATION: FASCICULATIONS BEHAVIORAL: ATAXIA | Human Toxicology. Vol. 3, Pg. 141, 1984. |
women | TDLo | oral | 36mg/kg/9D-I (36mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" | British Medical Journal. Vol. 287, Pg. 1181, 1983. |
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. Human systemic effects: ataxia, diarrhea, fasciculations, hypermotility, jaundice. An experimental teratogen. Experimental reproductive effects. When heated to decomposition Zimeldine hydrochloride (CAS NO.60525-15-7) emits toxic fumes of Br−, NOx, and HCl. See also ZIMELIDINE.
Zimeldine hydrochloride , its cas register number is 60525-15-7. It also can be called Zimeldine ; Zimelidine hydrochloride ; and Zelmid .